

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 7.32313373 |
| 2 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 6.36293408 |
| 3 | vocalization behavior (GO:0071625) | 5.91818534 |
| 4 | tongue development (GO:0043586) | 5.50106702 |
| 5 | glutamate receptor signaling pathway (GO:0007215) | 5.32817579 |
| 6 | glutamate secretion (GO:0014047) | 5.23701735 |
| 7 | synaptic vesicle maturation (GO:0016188) | 5.18325973 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.15126759 |
| 9 | synaptic transmission, glutamatergic (GO:0035249) | 5.04221578 |
| 10 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.04136857 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.96978790 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.91354942 |
| 13 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.87102528 |
| 14 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.81422987 |
| 15 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.65196531 |
| 16 | neuron-neuron synaptic transmission (GO:0007270) | 4.64714896 |
| 17 | locomotory exploration behavior (GO:0035641) | 4.63325964 |
| 18 | proline transport (GO:0015824) | 4.57855185 |
| 19 | neuron cell-cell adhesion (GO:0007158) | 4.57305928 |
| 20 | protein localization to synapse (GO:0035418) | 4.50994070 |
| 21 | exploration behavior (GO:0035640) | 4.49364059 |
| 22 | neuron recognition (GO:0008038) | 4.42917759 |
| 23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.40389340 |
| 24 | synaptic vesicle exocytosis (GO:0016079) | 4.27552422 |
| 25 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.22150542 |
| 26 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.17662159 |
| 27 | neurotransmitter secretion (GO:0007269) | 4.13074052 |
| 28 | long-term memory (GO:0007616) | 4.12249302 |
| 29 | * behavioral defense response (GO:0002209) | 4.10585874 |
| 30 | * behavioral fear response (GO:0001662) | 4.10585874 |
| 31 | neuronal action potential propagation (GO:0019227) | 4.10321870 |
| 32 | ovulation cycle (GO:0042698) | 4.09109168 |
| 33 | estrogen biosynthetic process (GO:0006703) | 4.01629285 |
| 34 | positive regulation of synapse maturation (GO:0090129) | 4.01274841 |
| 35 | response to histamine (GO:0034776) | 3.98496156 |
| 36 | long-term synaptic potentiation (GO:0060291) | 3.85112891 |
| 37 | regulation of synaptic plasticity (GO:0048167) | 3.84095216 |
| 38 | * regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.80537265 |
| 39 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.76226710 |
| 40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.73428078 |
| 41 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.72461069 |
| 42 | neuronal stem cell maintenance (GO:0097150) | 3.70476260 |
| 43 | cellular potassium ion homeostasis (GO:0030007) | 3.70475840 |
| 44 | regulation of male gonad development (GO:2000018) | 3.69235424 |
| 45 | amyloid precursor protein catabolic process (GO:0042987) | 3.68604797 |
| 46 | neuromuscular process controlling posture (GO:0050884) | 3.67716430 |
| 47 | * fear response (GO:0042596) | 3.66435401 |
| 48 | regulation of synapse structural plasticity (GO:0051823) | 3.65748020 |
| 49 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.65005614 |
| 50 | retinal ganglion cell axon guidance (GO:0031290) | 3.63530715 |
| 51 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.62825435 |
| 52 | serotonin receptor signaling pathway (GO:0007210) | 3.59822171 |
| 53 | transmission of nerve impulse (GO:0019226) | 3.58840201 |
| 54 | embryonic digestive tract development (GO:0048566) | 3.57734065 |
| 55 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.57594782 |
| 56 | * regulation of postsynaptic membrane potential (GO:0060078) | 3.56782701 |
| 57 | regulation of synaptic vesicle transport (GO:1902803) | 3.55257262 |
| 58 | * regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.49718787 |
| 59 | cerebral cortex cell migration (GO:0021795) | 3.49269359 |
| 60 | gonadal mesoderm development (GO:0007506) | 3.49037823 |
| 61 | neurotransmitter transport (GO:0006836) | 3.48069589 |
| 62 | suckling behavior (GO:0001967) | 3.45535745 |
| 63 | cell communication by electrical coupling (GO:0010644) | 3.45397488 |
| 64 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.44700857 |
| 65 | membrane depolarization during action potential (GO:0086010) | 3.41912524 |
| 66 | startle response (GO:0001964) | 3.41735679 |
| 67 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.41152679 |
| 68 | positive regulation of membrane potential (GO:0045838) | 3.40829426 |
| 69 | * negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.39210326 |
| 70 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.38150827 |
| 71 | dendrite morphogenesis (GO:0048813) | 3.37873008 |
| 72 | chemosensory behavior (GO:0007635) | 3.37736949 |
| 73 | DNA strand renaturation (GO:0000733) | 3.37457589 |
| 74 | positive regulation of catenin import into nucleus (GO:0035413) | 3.37397889 |
| 75 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.37251200 |
| 76 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.36559208 |
| 77 | nonmotile primary cilium assembly (GO:0035058) | 3.35234544 |
| 78 | drinking behavior (GO:0042756) | 3.34322930 |
| 79 | cell proliferation in forebrain (GO:0021846) | 3.34200832 |
| 80 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.34068243 |
| 81 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.31874776 |
| 82 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.31336297 |
| 83 | axonal fasciculation (GO:0007413) | 3.31275857 |
| 84 | presynaptic membrane assembly (GO:0097105) | 3.31136448 |
| 85 | alpha-linolenic acid metabolic process (GO:0036109) | 3.30593511 |
| 86 | auditory behavior (GO:0031223) | 3.29180899 |
| 87 | sequestering of actin monomers (GO:0042989) | 3.28116954 |
| 88 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.27687731 |
| 89 | vitamin transmembrane transport (GO:0035461) | 3.27224429 |
| 90 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.25746876 |
| 91 | nucleobase catabolic process (GO:0046113) | 3.25180808 |
| 92 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.24794111 |
| 93 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.23356374 |
| 94 | * membrane depolarization (GO:0051899) | 3.22831061 |
| 95 | regulation of neurotransmitter levels (GO:0001505) | 3.22250124 |
| 96 | neuronal ion channel clustering (GO:0045161) | 3.21745564 |
| 97 | synaptic transmission (GO:0007268) | 3.21378027 |
| 98 | innervation (GO:0060384) | 3.21092417 |
| 99 | membrane hyperpolarization (GO:0060081) | 3.20705454 |
| 100 | cellular sodium ion homeostasis (GO:0006883) | 3.19368404 |
| 101 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.19321303 |
| 102 | cerebellar granule cell differentiation (GO:0021707) | 3.19136662 |
| 103 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.18515927 |
| 104 | regulation of synapse maturation (GO:0090128) | 3.18491289 |
| 105 | axon extension involved in axon guidance (GO:0048846) | 3.17526745 |
| 106 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.17526745 |
| 107 | dendritic spine morphogenesis (GO:0060997) | 3.15547030 |
| 108 | postsynaptic membrane organization (GO:0001941) | 3.10829375 |
| 109 | serotonin metabolic process (GO:0042428) | 3.10197603 |
| 110 | sodium ion export (GO:0071436) | 3.09636956 |
| 111 | learning (GO:0007612) | 3.08103772 |
| 112 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.08006259 |
| 113 | digestive tract morphogenesis (GO:0048546) | 3.07847764 |
| 114 | gamma-aminobutyric acid transport (GO:0015812) | 3.06948672 |
| 115 | mechanosensory behavior (GO:0007638) | 3.05922292 |
| 116 | somite development (GO:0061053) | 3.05877336 |
| 117 | * regulation of synaptic transmission (GO:0050804) | 3.05080163 |
| 118 | folic acid transport (GO:0015884) | 3.02838106 |
| 119 | mating behavior (GO:0007617) | 3.02083903 |
| 120 | synaptic vesicle endocytosis (GO:0048488) | 3.01567572 |
| 121 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.00292485 |
| 122 | positive regulation of action potential (GO:0045760) | 3.00260376 |
| 123 | positive regulation of synaptic transmission (GO:0050806) | 2.97641287 |
| 124 | protein K6-linked ubiquitination (GO:0085020) | 2.95395415 |
| 125 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.95084622 |
| 126 | positive regulation of dendritic spine development (GO:0060999) | 2.94995065 |
| 127 | presynaptic membrane organization (GO:0097090) | 2.94468246 |
| 128 | activation of protein kinase A activity (GO:0034199) | 2.91931495 |
| 129 | clathrin coat assembly (GO:0048268) | 2.91210347 |
| 130 | regulation of glutamate secretion (GO:0014048) | 2.90048403 |
| 131 | positive regulation of male gonad development (GO:2000020) | 2.89523995 |
| 132 | response to pheromone (GO:0019236) | 2.89004549 |
| 133 | radial glial cell differentiation (GO:0060019) | 2.88193435 |
| 134 | C4-dicarboxylate transport (GO:0015740) | 2.88088349 |
| 135 | regulation of vesicle fusion (GO:0031338) | 2.87677025 |
| 136 | striatum development (GO:0021756) | 2.86871434 |
| 137 | calcium ion-dependent exocytosis (GO:0017156) | 2.86487349 |
| 138 | regulation of respiratory system process (GO:0044065) | 2.86255899 |
| 139 | detection of calcium ion (GO:0005513) | 2.85915786 |
| 140 | limb development (GO:0060173) | 2.80800294 |
| 141 | appendage development (GO:0048736) | 2.80800294 |
| 142 | * regulation of dopamine secretion (GO:0014059) | 2.77574598 |
| 143 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.75781802 |
| 144 | limb bud formation (GO:0060174) | 2.73693248 |
| 145 | regulation of axon guidance (GO:1902667) | 2.72697715 |
| 146 | negative chemotaxis (GO:0050919) | 2.69928332 |
| 147 | glucocorticoid biosynthetic process (GO:0006704) | 2.69189216 |
| 148 | positive regulation of neuroblast proliferation (GO:0002052) | 2.68764929 |
| 149 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.65269750 |
| 150 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.65269750 |
| 151 | axon ensheathment in central nervous system (GO:0032291) | 2.63683843 |
| 152 | central nervous system myelination (GO:0022010) | 2.63683843 |
| 153 | paraxial mesoderm development (GO:0048339) | 2.61825909 |
| 154 | neurotransmitter uptake (GO:0001504) | 2.59518370 |
| 155 | axon extension (GO:0048675) | 2.59387385 |
| 156 | negative regulation of smoothened signaling pathway (GO:0045879) | 2.57024504 |
| 157 | positive regulation of synapse assembly (GO:0051965) | 2.56026368 |
| 158 | hippocampus development (GO:0021766) | 2.54240410 |
| 159 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.52467699 |
| 160 | regulation of action potential (GO:0098900) | 2.50777455 |
| 161 | potassium ion import (GO:0010107) | 2.48787981 |
| 162 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.48187246 |
| 163 | retinal cone cell development (GO:0046549) | 2.45369089 |
| 164 | platelet dense granule organization (GO:0060155) | 2.45110737 |
| 165 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.44094029 |
| 166 | amyloid precursor protein metabolic process (GO:0042982) | 2.41302377 |
| 167 | homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 2.40578889 |
| 168 | regulation of oxidative stress-induced neuron death (GO:1903203) | 2.39817095 |
| 169 | ephrin receptor signaling pathway (GO:0048013) | 2.39186988 |
| 170 | response to leptin (GO:0044321) | 2.38712392 |
| 171 | protein import into peroxisome matrix (GO:0016558) | 2.37401492 |
| 172 | negative regulation of glial cell differentiation (GO:0045686) | 2.36478700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.76304221 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.85449992 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.17010857 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.02967800 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.93174263 |
| 6 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.69464468 |
| 7 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.62949998 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.62458229 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.62458229 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.62097448 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.56727185 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.50604376 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.49985231 |
| 14 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.46422769 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.45333213 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43237579 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.41383956 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.41374281 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.38983922 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.27905923 |
| 21 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.26960829 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.26771421 |
| 23 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.20397279 |
| 24 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.17772556 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.16328196 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.12081403 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.10200253 |
| 28 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.03395606 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02778840 |
| 30 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.01213003 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.93115549 |
| 32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.91260425 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.90621411 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.81897787 |
| 35 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.80759242 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.68384583 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.68296286 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.65518105 |
| 39 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62302031 |
| 40 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.58476043 |
| 41 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.58093322 |
| 42 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.52230124 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50362511 |
| 44 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.50026262 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.49731292 |
| 46 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.47199129 |
| 47 | FUS_26573619_Chip-Seq_HEK293_Human | 1.47071121 |
| 48 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.44256069 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42676431 |
| 50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42302695 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41598546 |
| 52 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.41074812 |
| 53 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.40066983 |
| 54 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39021470 |
| 55 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.38974478 |
| 56 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38831404 |
| 57 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38622171 |
| 58 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.37760788 |
| 59 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.35860113 |
| 60 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34759053 |
| 61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32217154 |
| 62 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30850175 |
| 63 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.29820028 |
| 64 | VDR_22108803_ChIP-Seq_LS180_Human | 1.29049463 |
| 65 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28109997 |
| 66 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.27085541 |
| 67 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26944335 |
| 68 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.24987747 |
| 69 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.21745116 |
| 70 | JUN_21703547_ChIP-Seq_K562_Human | 1.21741849 |
| 71 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.20174204 |
| 72 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19978668 |
| 73 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19618741 |
| 74 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.16772360 |
| 75 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.15978118 |
| 76 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.15961745 |
| 77 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.14576251 |
| 78 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13763422 |
| 79 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13095909 |
| 80 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12388483 |
| 81 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.11743724 |
| 82 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.11668173 |
| 83 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.08860870 |
| 84 | AR_19668381_ChIP-Seq_PC3_Human | 1.08592373 |
| 85 | TCF4_23295773_ChIP-Seq_U87_Human | 1.07886783 |
| 86 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07034855 |
| 87 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07034855 |
| 88 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06801891 |
| 89 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04886654 |
| 90 | * SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.04441797 |
| 91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04005287 |
| 92 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03876320 |
| 93 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01586588 |
| 94 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01325133 |
| 95 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.00906077 |
| 96 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.00822660 |
| 97 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00573020 |
| 98 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00114544 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99944420 |
| 100 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99706950 |
| 101 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99684580 |
| 102 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99165933 |
| 103 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.98366233 |
| 104 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96176160 |
| 105 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95182498 |
| 106 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94271050 |
| 107 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.94157007 |
| 108 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94092272 |
| 109 | EWS_26573619_Chip-Seq_HEK293_Human | 0.93892871 |
| 110 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.92041802 |
| 111 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91910200 |
| 112 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.90917623 |
| 113 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90002591 |
| 114 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.89767029 |
| 115 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89377598 |
| 116 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.88141283 |
| 117 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.86025634 |
| 118 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.85495384 |
| 119 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85247913 |
| 120 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.84780419 |
| 121 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.84382189 |
| 122 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.83366764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.42978047 |
| 2 | MP0003880_abnormal_central_pattern | 5.09356781 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.14396192 |
| 4 | MP0002735_abnormal_chemical_nociception | 3.73942786 |
| 5 | * MP0009745_abnormal_behavioral_response | 3.60642402 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.54408868 |
| 7 | * MP0002063_abnormal_learning/memory/cond | 3.42468009 |
| 8 | MP0009379_abnormal_foot_pigmentation | 3.28541917 |
| 9 | * MP0002064_seizures | 3.25964997 |
| 10 | MP0002736_abnormal_nociception_after | 3.10816440 |
| 11 | * MP0002572_abnormal_emotion/affect_behav | 2.97350772 |
| 12 | MP0004270_analgesia | 2.95898414 |
| 13 | MP0005248_abnormal_Harderian_gland | 2.92270554 |
| 14 | MP0002653_abnormal_ependyma_morphology | 2.90104978 |
| 15 | MP0010030_abnormal_orbit_morphology | 2.87132810 |
| 16 | MP0002272_abnormal_nervous_system | 2.84061814 |
| 17 | MP0002822_catalepsy | 2.71287201 |
| 18 | MP0009053_abnormal_anal_canal | 2.60846621 |
| 19 | MP0009046_muscle_twitch | 2.47435188 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.37408949 |
| 21 | MP0008877_abnormal_DNA_methylation | 2.20037609 |
| 22 | * MP0001501_abnormal_sleep_pattern | 2.11252503 |
| 23 | MP0000566_synostosis | 2.09843019 |
| 24 | MP0001486_abnormal_startle_reflex | 2.07262593 |
| 25 | MP0003011_delayed_dark_adaptation | 2.07179346 |
| 26 | MP0002734_abnormal_mechanical_nocicepti | 2.05897728 |
| 27 | MP0006276_abnormal_autonomic_nervous | 2.00566125 |
| 28 | MP0003329_amyloid_beta_deposits | 1.95937083 |
| 29 | MP0005394_taste/olfaction_phenotype | 1.95903592 |
| 30 | MP0005499_abnormal_olfactory_system | 1.95903592 |
| 31 | * MP0002067_abnormal_sensory_capabilities | 1.93872810 |
| 32 | MP0004858_abnormal_nervous_system | 1.90074553 |
| 33 | MP0002233_abnormal_nose_morphology | 1.89785938 |
| 34 | MP0002184_abnormal_innervation | 1.88274595 |
| 35 | MP0005423_abnormal_somatic_nervous | 1.87334454 |
| 36 | MP0001970_abnormal_pain_threshold | 1.86174048 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.85650407 |
| 38 | MP0008789_abnormal_olfactory_epithelium | 1.81385484 |
| 39 | MP0000579_abnormal_nail_morphology | 1.80626925 |
| 40 | MP0001293_anophthalmia | 1.75327167 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.67998835 |
| 42 | MP0009780_abnormal_chondrocyte_physiolo | 1.66972842 |
| 43 | MP0002557_abnormal_social/conspecific_i | 1.66735837 |
| 44 | MP0000383_abnormal_hair_follicle | 1.66673892 |
| 45 | MP0008004_abnormal_stomach_pH | 1.66397549 |
| 46 | MP0002638_abnormal_pupillary_reflex | 1.64508572 |
| 47 | MP0000955_abnormal_spinal_cord | 1.62652771 |
| 48 | MP0004811_abnormal_neuron_physiology | 1.61798773 |
| 49 | MP0003122_maternal_imprinting | 1.58898831 |
| 50 | MP0003787_abnormal_imprinting | 1.55005383 |
| 51 | MP0000778_abnormal_nervous_system | 1.51394724 |
| 52 | MP0003879_abnormal_hair_cell | 1.46936470 |
| 53 | MP0009384_cardiac_valve_regurgitation | 1.44419192 |
| 54 | MP0004885_abnormal_endolymph | 1.41194824 |
| 55 | MP0004924_abnormal_behavior | 1.37711877 |
| 56 | MP0005386_behavior/neurological_phenoty | 1.37711877 |
| 57 | MP0000049_abnormal_middle_ear | 1.36796803 |
| 58 | MP0001905_abnormal_dopamine_level | 1.36545208 |
| 59 | MP0008569_lethality_at_weaning | 1.36179738 |
| 60 | MP0004142_abnormal_muscle_tone | 1.36080960 |
| 61 | MP0002697_abnormal_eye_size | 1.34950384 |
| 62 | * MP0002882_abnormal_neuron_morphology | 1.33814702 |
| 63 | * MP0002066_abnormal_motor_capabilities/c | 1.31191561 |
| 64 | MP0008775_abnormal_heart_ventricle | 1.30231703 |
| 65 | MP0000751_myopathy | 1.28502780 |
| 66 | MP0002932_abnormal_joint_morphology | 1.27366947 |
| 67 | MP0002909_abnormal_adrenal_gland | 1.26337267 |
| 68 | MP0002234_abnormal_pharynx_morphology | 1.25535741 |
| 69 | MP0005253_abnormal_eye_physiology | 1.23484804 |
| 70 | MP0010368_abnormal_lymphatic_system | 1.23236391 |
| 71 | MP0003136_yellow_coat_color | 1.22035434 |
| 72 | MP0001286_abnormal_eye_development | 1.21332307 |
| 73 | MP0003123_paternal_imprinting | 1.20852263 |
| 74 | MP0001188_hyperpigmentation | 1.20028541 |
| 75 | MP0003755_abnormal_palate_morphology | 1.18377201 |
| 76 | MP0005187_abnormal_penis_morphology | 1.18295557 |
| 77 | MP0003937_abnormal_limbs/digits/tail_de | 1.17573286 |
| 78 | MP0002876_abnormal_thyroid_physiology | 1.16793693 |
| 79 | MP0000013_abnormal_adipose_tissue | 1.15995983 |
| 80 | MP0001984_abnormal_olfaction | 1.15921324 |
| 81 | MP0000631_abnormal_neuroendocrine_gland | 1.15505965 |
| 82 | MP0005645_abnormal_hypothalamus_physiol | 1.11469069 |
| 83 | MP0002938_white_spotting | 1.11110797 |
| 84 | MP0006072_abnormal_retinal_apoptosis | 1.08321744 |
| 85 | MP0003633_abnormal_nervous_system | 1.06291361 |
| 86 | * MP0003861_abnormal_nervous_system | 1.04983576 |
| 87 | MP0000604_amyloidosis | 1.03188118 |
| 88 | MP0002249_abnormal_larynx_morphology | 1.03048000 |
| 89 | MP0010678_abnormal_skin_adnexa | 1.02899188 |
| 90 | MP0005391_vision/eye_phenotype | 1.01641933 |
| 91 | MP0003385_abnormal_body_wall | 1.01545838 |
| 92 | MP0003119_abnormal_digestive_system | 1.01421666 |
| 93 | MP0005670_abnormal_white_adipose | 1.01184868 |
| 94 | MP0001502_abnormal_circadian_rhythm | 0.98388394 |
| 95 | MP0008872_abnormal_physiological_respon | 0.97749735 |
| 96 | MP0002282_abnormal_trachea_morphology | 0.96292911 |
| 97 | MP0003631_nervous_system_phenotype | 0.95514877 |
| 98 | MP0000537_abnormal_urethra_morphology | 0.95038454 |
| 99 | MP0008874_decreased_physiological_sensi | 0.93473503 |
| 100 | MP0003634_abnormal_glial_cell | 0.92798283 |
| 101 | * MP0002069_abnormal_eating/drinking_beha | 0.92608343 |
| 102 | MP0003075_altered_response_to | 0.91682917 |
| 103 | MP0005197_abnormal_uvea_morphology | 0.90903808 |
| 104 | MP0000462_abnormal_digestive_system | 0.90416577 |
| 105 | MP0005195_abnormal_posterior_eye | 0.88864591 |
| 106 | MP0001529_abnormal_vocalization | 0.88111232 |
| 107 | MP0002837_dystrophic_cardiac_calcinosis | 0.87944372 |
| 108 | MP0009250_abnormal_appendicular_skeleto | 0.87804067 |
| 109 | * MP0002152_abnormal_brain_morphology | 0.87616923 |
| 110 | MP0001986_abnormal_taste_sensitivity | 0.87356219 |
| 111 | MP0000647_abnormal_sebaceous_gland | 0.86820202 |
| 112 | MP0001963_abnormal_hearing_physiology | 0.86043214 |
| 113 | MP0000427_abnormal_hair_cycle | 0.84846893 |
| 114 | MP0000534_abnormal_ureter_morphology | 0.84649835 |
| 115 | * MP0004085_abnormal_heartbeat | 0.84418015 |
| 116 | MP0001340_abnormal_eyelid_morphology | 0.84122431 |
| 117 | MP0005623_abnormal_meninges_morphology | 0.82979061 |
| 118 | MP0005171_absent_coat_pigmentation | 0.82903641 |
| 119 | MP0005367_renal/urinary_system_phenotyp | 0.82061007 |
| 120 | MP0000516_abnormal_urinary_system | 0.82061007 |
| 121 | MP0000747_muscle_weakness | 0.80107292 |
| 122 | MP0004484_altered_response_of | 0.78481183 |
| 123 | MP0002229_neurodegeneration | 0.78021461 |
| 124 | MP0002092_abnormal_eye_morphology | 0.75580474 |
| 125 | MP0003632_abnormal_nervous_system | 0.75453942 |
| 126 | MP0002109_abnormal_limb_morphology | 0.75009703 |
| 127 | MP0003690_abnormal_glial_cell | 0.74601334 |
| 128 | MP0004215_abnormal_myocardial_fiber | 0.73788873 |
| 129 | MP0003938_abnormal_ear_development | 0.73720753 |
| 130 | MP0003567_abnormal_fetal_cardiomyocyte | 0.73150647 |
| 131 | MP0004510_myositis | 0.72721126 |
| 132 | MP0002116_abnormal_craniofacial_bone | 0.72063399 |
| 133 | * MP0002752_abnormal_somatic_nervous | 0.71624106 |
| 134 | MP0004742_abnormal_vestibular_system | 0.68150063 |
| 135 | MP0000749_muscle_degeneration | 0.67874684 |
| 136 | MP0005535_abnormal_body_temperature | 0.63990444 |
| 137 | MP0005551_abnormal_eye_electrophysiolog | 0.62678358 |
| 138 | MP0001664_abnormal_digestion | 0.62248791 |
| 139 | MP0001177_atelectasis | 0.61181242 |
| 140 | MP0001299_abnormal_eye_distance/ | 0.59045330 |
| 141 | MP0002751_abnormal_autonomic_nervous | 0.56823239 |
| 142 | MP0001485_abnormal_pinna_reflex | 0.55790239 |
| 143 | MP0005595_abnormal_vascular_smooth | 0.55581717 |
| 144 | MP0005409_darkened_coat_color | 0.55383868 |
| 145 | MP0010386_abnormal_urinary_bladder | 0.53042218 |
| 146 | MP0003121_genomic_imprinting | 0.52552817 |
| 147 | MP0000026_abnormal_inner_ear | 0.51506898 |
| 148 | MP0004145_abnormal_muscle_electrophysio | 0.51489271 |
| 149 | MP0000920_abnormal_myelination | 0.51416890 |
| 150 | MP0006292_abnormal_olfactory_placode | 0.50515903 |
| 151 | MP0001943_abnormal_respiration | 0.50144946 |
| 152 | MP0001765_abnormal_ion_homeostasis | 0.49150159 |
| 153 | MP0003137_abnormal_impulse_conducting | 0.48251285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.11867188 |
| 2 | Myokymia (HP:0002411) | 6.12324838 |
| 3 | Atonic seizures (HP:0010819) | 5.56721389 |
| 4 | Focal seizures (HP:0007359) | 5.52887168 |
| 5 | Febrile seizures (HP:0002373) | 5.01688543 |
| 6 | Epileptic encephalopathy (HP:0200134) | 5.01042344 |
| 7 | Retinal dysplasia (HP:0007973) | 4.71298985 |
| 8 | Visual hallucinations (HP:0002367) | 4.67117891 |
| 9 | Absence seizures (HP:0002121) | 4.61375371 |
| 10 | Dialeptic seizures (HP:0011146) | 4.45097950 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.08907856 |
| 12 | Hyperventilation (HP:0002883) | 3.90769490 |
| 13 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 3.86736816 |
| 14 | Anomalous pulmonary venous return (HP:0010772) | 3.86628966 |
| 15 | Vitreoretinal degeneration (HP:0000655) | 3.84757270 |
| 16 | Hypoventilation (HP:0002791) | 3.56502043 |
| 17 | Progressive cerebellar ataxia (HP:0002073) | 3.51725612 |
| 18 | Type II lissencephaly (HP:0007260) | 3.46007820 |
| 19 | Split foot (HP:0001839) | 3.38519831 |
| 20 | Abnormal social behavior (HP:0012433) | 3.37134136 |
| 21 | Impaired social interactions (HP:0000735) | 3.37134136 |
| 22 | Hypoplastic pelvis (HP:0008839) | 3.36364111 |
| 23 | Calf muscle hypertrophy (HP:0008981) | 3.32004167 |
| 24 | Poor eye contact (HP:0000817) | 3.29289415 |
| 25 | Shoulder girdle muscle weakness (HP:0003547) | 3.28548950 |
| 26 | Amblyopia (HP:0000646) | 3.28210282 |
| 27 | Abnormality of the pulmonary veins (HP:0011718) | 3.24187517 |
| 28 | Action tremor (HP:0002345) | 3.05936309 |
| 29 | Abnormal eating behavior (HP:0100738) | 3.05868334 |
| 30 | Nephrogenic diabetes insipidus (HP:0009806) | 3.02153931 |
| 31 | Excessive salivation (HP:0003781) | 3.01181185 |
| 32 | Drooling (HP:0002307) | 3.01181185 |
| 33 | Abnormality of the aortic arch (HP:0012303) | 3.00212103 |
| 34 | Gaze-evoked nystagmus (HP:0000640) | 2.98973125 |
| 35 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.98931629 |
| 36 | Gait imbalance (HP:0002141) | 2.98442637 |
| 37 | Achilles tendon contracture (HP:0001771) | 2.96631283 |
| 38 | Broad-based gait (HP:0002136) | 2.95522602 |
| 39 | Congenital primary aphakia (HP:0007707) | 2.83965941 |
| 40 | Rib fusion (HP:0000902) | 2.82974453 |
| 41 | Partial agenesis of the corpus callosum (HP:0001338) | 2.79654266 |
| 42 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.78962788 |
| 43 | Medial flaring of the eyebrow (HP:0010747) | 2.78939977 |
| 44 | Progressive inability to walk (HP:0002505) | 2.75332705 |
| 45 | Oligodactyly (HP:0012165) | 2.71695176 |
| 46 | Abnormality of the Achilles tendon (HP:0005109) | 2.70246486 |
| 47 | Anophthalmia (HP:0000528) | 2.70175281 |
| 48 | Pancreatic fibrosis (HP:0100732) | 2.68347563 |
| 49 | Dysmetria (HP:0001310) | 2.65442019 |
| 50 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.61718817 |
| 51 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.61718817 |
| 52 | Dysdiadochokinesis (HP:0002075) | 2.56894637 |
| 53 | Large earlobe (HP:0009748) | 2.55846289 |
| 54 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 2.55194102 |
| 55 | Pelvic girdle muscle weakness (HP:0003749) | 2.55002978 |
| 56 | Limb-girdle muscle atrophy (HP:0003797) | 2.54543597 |
| 57 | Truncal ataxia (HP:0002078) | 2.53645733 |
| 58 | Abnormal ciliary motility (HP:0012262) | 2.53391592 |
| 59 | Epileptiform EEG discharges (HP:0011182) | 2.51989236 |
| 60 | Anxiety (HP:0000739) | 2.50065480 |
| 61 | Abnormal lung lobation (HP:0002101) | 2.49936389 |
| 62 | Postural instability (HP:0002172) | 2.49491315 |
| 63 | True hermaphroditism (HP:0010459) | 2.48757409 |
| 64 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.48384120 |
| 65 | Arthropathy (HP:0003040) | 2.47098371 |
| 66 | Abnormality of the diencephalon (HP:0010662) | 2.46760862 |
| 67 | Vaginal atresia (HP:0000148) | 2.45326045 |
| 68 | Renal dysplasia (HP:0000110) | 2.44864978 |
| 69 | Vertebral clefting (HP:0008428) | 2.44035841 |
| 70 | Fetal akinesia sequence (HP:0001989) | 2.42962968 |
| 71 | Supranuclear gaze palsy (HP:0000605) | 2.42411580 |
| 72 | Delayed gross motor development (HP:0002194) | 2.42215077 |
| 73 | Cerebral inclusion bodies (HP:0100314) | 2.41796223 |
| 74 | Mutism (HP:0002300) | 2.40971031 |
| 75 | Depression (HP:0000716) | 2.40185834 |
| 76 | Hemiparesis (HP:0001269) | 2.36702378 |
| 77 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.34006071 |
| 78 | Abnormality of the lower motor neuron (HP:0002366) | 2.33686319 |
| 79 | Cupped ear (HP:0000378) | 2.31235955 |
| 80 | Postaxial hand polydactyly (HP:0001162) | 2.30370010 |
| 81 | Abnormality of the 2nd finger (HP:0004100) | 2.30319709 |
| 82 | Oligodactyly (hands) (HP:0001180) | 2.30108934 |
| 83 | Genital tract atresia (HP:0001827) | 2.28451071 |
| 84 | Renal hypoplasia (HP:0000089) | 2.28079979 |
| 85 | EEG with generalized epileptiform discharges (HP:0011198) | 2.27827043 |
| 86 | Absent speech (HP:0001344) | 2.26693865 |
| 87 | Polyphagia (HP:0002591) | 2.24144110 |
| 88 | Increased circulating renin level (HP:0000848) | 2.23948763 |
| 89 | Broad distal phalanx of finger (HP:0009836) | 2.21166984 |
| 90 | Torticollis (HP:0000473) | 2.20818180 |
| 91 | Abnormality of the calf musculature (HP:0001430) | 2.20160729 |
| 92 | Septo-optic dysplasia (HP:0100842) | 2.17016878 |
| 93 | Postaxial foot polydactyly (HP:0001830) | 2.15535600 |
| 94 | Stenosis of the external auditory canal (HP:0000402) | 2.13244639 |
| 95 | Facial hemangioma (HP:0000329) | 2.12805534 |
| 96 | Hypsarrhythmia (HP:0002521) | 2.11361689 |
| 97 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.10208297 |
| 98 | Absent/shortened dynein arms (HP:0200106) | 2.10208297 |
| 99 | Hemiplegia (HP:0002301) | 2.10184918 |
| 100 | Anterior segment dysgenesis (HP:0007700) | 2.10066687 |
| 101 | Neurofibrillary tangles (HP:0002185) | 2.10059388 |
| 102 | Sensorimotor neuropathy (HP:0007141) | 2.10056645 |
| 103 | Intestinal atresia (HP:0011100) | 2.09708286 |
| 104 | Pendular nystagmus (HP:0012043) | 2.08530980 |
| 105 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.06869602 |
| 106 | Decreased testicular size (HP:0008734) | 2.05720454 |
| 107 | Broad foot (HP:0001769) | 2.04766451 |
| 108 | Difficulty climbing stairs (HP:0003551) | 2.04492233 |
| 109 | Supernumerary spleens (HP:0009799) | 2.04327234 |
| 110 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.04178537 |
| 111 | Optic nerve hypoplasia (HP:0000609) | 2.04040127 |
| 112 | Decreased circulating renin level (HP:0003351) | 2.03290813 |
| 113 | Esotropia (HP:0000565) | 2.03077096 |
| 114 | Cerebellar dysplasia (HP:0007033) | 2.02617328 |
| 115 | Focal dystonia (HP:0004373) | 2.02545752 |
| 116 | Hip dysplasia (HP:0001385) | 2.01458926 |
| 117 | Cutaneous finger syndactyly (HP:0010554) | 2.00869914 |
| 118 | Frequent falls (HP:0002359) | 1.99419827 |
| 119 | Insidious onset (HP:0003587) | 1.99133338 |
| 120 | Termporal pattern (HP:0011008) | 1.99133338 |
| 121 | Abnormality of salivation (HP:0100755) | 1.98958289 |
| 122 | Inability to walk (HP:0002540) | 1.98070853 |
| 123 | Fibular hypoplasia (HP:0003038) | 1.97321243 |
| 124 | Scanning speech (HP:0002168) | 1.96903915 |
| 125 | Ankle clonus (HP:0011448) | 1.95836475 |
| 126 | Increased variability in muscle fiber diameter (HP:0003557) | 1.95455609 |
| 127 | Limb dystonia (HP:0002451) | 1.95159701 |
| 128 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.94610293 |
| 129 | Blue irides (HP:0000635) | 1.94375103 |
| 130 | Intention tremor (HP:0002080) | 1.94148781 |
| 131 | Hypoplasia of the brainstem (HP:0002365) | 1.93971830 |
| 132 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.93971830 |
| 133 | Hyperactive renin-angiotensin system (HP:0000841) | 1.93525228 |
| 134 | Nonprogressive disorder (HP:0003680) | 1.92851874 |
| 135 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.92430892 |
| 136 | Agitation (HP:0000713) | 1.92029744 |
| 137 | Diplopia (HP:0000651) | 1.91113988 |
| 138 | Abnormality of binocular vision (HP:0011514) | 1.91113988 |
| 139 | Poor coordination (HP:0002370) | 1.90976275 |
| 140 | Spastic gait (HP:0002064) | 1.89926095 |
| 141 | Sclerocornea (HP:0000647) | 1.89013915 |
| 142 | Status epilepticus (HP:0002133) | 1.87411242 |
| 143 | Widely spaced teeth (HP:0000687) | 1.87392946 |
| 144 | Abnormality of the corticospinal tract (HP:0002492) | 1.86918852 |
| 145 | Lissencephaly (HP:0001339) | 1.86583203 |
| 146 | Annular pancreas (HP:0001734) | 1.86074719 |
| 147 | Abnormal EKG (HP:0003115) | 1.85940343 |
| 148 | Hyperthyroidism (HP:0000836) | 1.85678366 |
| 149 | Hypoplasia of the pons (HP:0012110) | 1.85016798 |
| 150 | Poor suck (HP:0002033) | 1.84978536 |
| 151 | Severe muscular hypotonia (HP:0006829) | 1.84944983 |
| 152 | Ventricular fibrillation (HP:0001663) | 1.84032809 |
| 153 | Hypoplasia of the ulna (HP:0003022) | 1.83930064 |
| 154 | Urinary urgency (HP:0000012) | 1.83493007 |
| 155 | Bradykinesia (HP:0002067) | 1.83319784 |
| 156 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.83000011 |
| 157 | Absent epiphyses (HP:0010577) | 1.83000011 |
| 158 | Micropenis (HP:0000054) | 1.82673431 |
| 159 | Pancreatic cysts (HP:0001737) | 1.82588511 |
| 160 | Incomplete penetrance (HP:0003829) | 1.82396844 |
| 161 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.82166286 |
| 162 | Hyperglycinemia (HP:0002154) | 1.81037869 |
| 163 | Flat capital femoral epiphysis (HP:0003370) | 1.80015187 |
| 164 | Stereotypic behavior (HP:0000733) | 1.79142406 |
| 165 | Abnormality of the intervertebral disk (HP:0005108) | 1.78268695 |
| 166 | Delusions (HP:0000746) | 1.78170571 |
| 167 | Short foot (HP:0001773) | 1.78093825 |
| 168 | Short 5th finger (HP:0009237) | 1.76250131 |
| 169 | Bicornuate uterus (HP:0000813) | 1.75677883 |
| 170 | Occipital encephalocele (HP:0002085) | 1.75595566 |
| 171 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.75586874 |
| 172 | Short 4th metacarpal (HP:0010044) | 1.74884012 |
| 173 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.74884012 |
| 174 | Abnormal biliary tract physiology (HP:0012439) | 1.74641808 |
| 175 | Bile duct proliferation (HP:0001408) | 1.74641808 |
| 176 | Abnormality of midbrain morphology (HP:0002418) | 1.73302941 |
| 177 | Molar tooth sign on MRI (HP:0002419) | 1.73302941 |
| 178 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.72195447 |
| 179 | Amyotrophic lateral sclerosis (HP:0007354) | 1.72042221 |
| 180 | Narrow nasal bridge (HP:0000446) | 1.72035457 |
| 181 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.71849403 |
| 182 | Cutaneous syndactyly (HP:0012725) | 1.70437203 |
| 183 | Specific learning disability (HP:0001328) | 1.69780313 |
| 184 | Failure to thrive in infancy (HP:0001531) | 1.68234851 |
| 185 | Tracheomalacia (HP:0002779) | 1.67825982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 5.75794799 |
| 2 | EPHA4 | 4.60449331 |
| 3 | PIK3CA | 4.19933637 |
| 4 | CASK | 3.84987174 |
| 5 | ERBB4 | 3.61035669 |
| 6 | MAP3K9 | 3.03219635 |
| 7 | MINK1 | 2.55110447 |
| 8 | BCKDK | 2.35465832 |
| 9 | NTRK2 | 2.29907781 |
| 10 | EPHB2 | 2.26104572 |
| 11 | MAP3K4 | 2.26096596 |
| 12 | DYRK2 | 2.21785011 |
| 13 | KSR2 | 2.17092606 |
| 14 | PLK2 | 2.12959572 |
| 15 | ARAF | 2.03047156 |
| 16 | RIPK4 | 2.02992799 |
| 17 | MAP2K7 | 2.02288570 |
| 18 | MAP3K12 | 2.00786049 |
| 19 | PRPF4B | 1.90505287 |
| 20 | PKN1 | 1.88418316 |
| 21 | STK38L | 1.87357314 |
| 22 | TESK2 | 1.83700069 |
| 23 | MAP3K13 | 1.75634971 |
| 24 | MARK1 | 1.72304986 |
| 25 | NUAK1 | 1.68936917 |
| 26 | PRKD3 | 1.63261734 |
| 27 | GRK5 | 1.61870915 |
| 28 | TNIK | 1.54351403 |
| 29 | PAK6 | 1.53595410 |
| 30 | PTK2B | 1.52948121 |
| 31 | KSR1 | 1.52675322 |
| 32 | PRKCG | 1.50001440 |
| 33 | STK16 | 1.45443860 |
| 34 | MUSK | 1.43274187 |
| 35 | MAPK13 | 1.42889677 |
| 36 | CSNK1G3 | 1.38747675 |
| 37 | CDK5 | 1.38333991 |
| 38 | DAPK2 | 1.37317332 |
| 39 | CAMK2A | 1.36437536 |
| 40 | MAP2K4 | 1.35938212 |
| 41 | DAPK1 | 1.35672654 |
| 42 | NTRK1 | 1.34928715 |
| 43 | MKNK1 | 1.34172663 |
| 44 | PLK3 | 1.30458194 |
| 45 | PRKCH | 1.27936202 |
| 46 | CAMKK1 | 1.24867397 |
| 47 | CAMK2B | 1.24216298 |
| 48 | CSNK1G1 | 1.23132656 |
| 49 | FES | 1.20548217 |
| 50 | SRPK1 | 1.20398166 |
| 51 | ERBB2 | 1.17068476 |
| 52 | CSNK1A1L | 1.15827243 |
| 53 | WNK3 | 1.14765654 |
| 54 | EPHA3 | 1.11817306 |
| 55 | TTK | 1.10415084 |
| 56 | CAMK1 | 1.08623117 |
| 57 | CAMKK2 | 1.05290316 |
| 58 | STK38 | 1.04434941 |
| 59 | PRKCE | 1.01997012 |
| 60 | SIK3 | 0.98527332 |
| 61 | FER | 0.96954889 |
| 62 | FRK | 0.96593209 |
| 63 | RAF1 | 0.95029438 |
| 64 | MKNK2 | 0.94944617 |
| 65 | AKT3 | 0.92275050 |
| 66 | SGK494 | 0.91739499 |
| 67 | SGK223 | 0.91739499 |
| 68 | MAP2K1 | 0.91594164 |
| 69 | RPS6KA5 | 0.88631361 |
| 70 | LMTK2 | 0.86716729 |
| 71 | MAP3K2 | 0.86357279 |
| 72 | CAMK4 | 0.85352453 |
| 73 | PINK1 | 0.83987901 |
| 74 | NME1 | 0.82996032 |
| 75 | MET | 0.82849805 |
| 76 | SIK2 | 0.81895248 |
| 77 | SGK2 | 0.80264056 |
| 78 | PAK3 | 0.79589815 |
| 79 | ZAK | 0.78460736 |
| 80 | PNCK | 0.78115020 |
| 81 | SGK1 | 0.77736044 |
| 82 | UHMK1 | 0.76162558 |
| 83 | TYRO3 | 0.76076665 |
| 84 | VRK1 | 0.75969074 |
| 85 | PBK | 0.75573636 |
| 86 | CCNB1 | 0.71039751 |
| 87 | STK11 | 0.70949414 |
| 88 | ATR | 0.69717755 |
| 89 | CSNK1A1 | 0.69638360 |
| 90 | BRAF | 0.69012344 |
| 91 | CAMK2D | 0.68859173 |
| 92 | LATS1 | 0.66472565 |
| 93 | CDK18 | 0.66064254 |
| 94 | ALK | 0.65722326 |
| 95 | CDK14 | 0.65376477 |
| 96 | MARK2 | 0.65189011 |
| 97 | DYRK1A | 0.64687933 |
| 98 | LATS2 | 0.64022591 |
| 99 | CSNK1D | 0.63170805 |
| 100 | CAMK2G | 0.61250196 |
| 101 | CDK15 | 0.60055338 |
| 102 | MAP3K1 | 0.59460620 |
| 103 | FGR | 0.59211432 |
| 104 | LIMK1 | 0.57238015 |
| 105 | PHKG2 | 0.56944670 |
| 106 | PHKG1 | 0.56944670 |
| 107 | JAK1 | 0.56129546 |
| 108 | YES1 | 0.55957789 |
| 109 | ROCK2 | 0.55742224 |
| 110 | CSNK1G2 | 0.55629902 |
| 111 | SGK3 | 0.55343714 |
| 112 | MAP3K7 | 0.54886729 |
| 113 | NEK1 | 0.54826553 |
| 114 | OXSR1 | 0.53873042 |
| 115 | PRKCA | 0.53542566 |
| 116 | NEK6 | 0.52740097 |
| 117 | RPS6KA3 | 0.52595707 |
| 118 | INSRR | 0.52417490 |
| 119 | MAPKAPK5 | 0.52046382 |
| 120 | PDK1 | 0.51901962 |
| 121 | TNK2 | 0.51801208 |
| 122 | PLK1 | 0.51438876 |
| 123 | PRKCB | 0.51292743 |
| 124 | CDK11A | 0.49716763 |
| 125 | BMPR2 | 0.49396819 |
| 126 | MOS | 0.48966360 |
| 127 | TRIM28 | 0.46883557 |
| 128 | ADRBK1 | 0.46863153 |
| 129 | BCR | 0.46732904 |
| 130 | FYN | 0.45415688 |
| 131 | AKT2 | 0.43693925 |
| 132 | DMPK | 0.43525846 |
| 133 | PDPK1 | 0.43337790 |
| 134 | CDK3 | 0.43278088 |
| 135 | PRKG1 | 0.42980179 |
| 136 | VRK2 | 0.42877305 |
| 137 | SRC | 0.42616698 |
| 138 | PRKACA | 0.42004281 |
| 139 | MAPK15 | 0.41844925 |
| 140 | MATK | 0.41197856 |
| 141 | PRKCZ | 0.40356790 |
| 142 | WEE1 | 0.38694425 |
| 143 | ERBB3 | 0.38539907 |
| 144 | ADRBK2 | 0.36329271 |
| 145 | CLK1 | 0.36300884 |
| 146 | CDK19 | 0.36146786 |
| 147 | STK3 | 0.36020276 |
| 148 | PRKACB | 0.35432922 |
| 149 | PRKACG | 0.34329238 |
| 150 | PLK4 | 0.34281497 |
| 151 | GRK6 | 0.33564097 |
| 152 | ATM | 0.33376178 |
| 153 | TIE1 | 0.32696105 |
| 154 | MAPK11 | 0.31792715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.79203500 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.11207980 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.01298369 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.96549965 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.88561831 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.88444250 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.85492283 |
| 8 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 2.59389541 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.54627508 |
| 10 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.45459842 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.41551100 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.40102249 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.31329254 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.22325927 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 2.12842184 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 2.06645868 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.00791726 |
| 18 | Basal cell carcinoma_Homo sapiens_hsa05217 | 2.00508098 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.93848392 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.88478908 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.87109575 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.85167326 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.84819420 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.83492868 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.81412789 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.80449144 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.74486255 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.65507199 |
| 29 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.62281113 |
| 30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.60264244 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.58676138 |
| 32 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.46141000 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.45768979 |
| 34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.44847693 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.43650116 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.43411316 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.41039975 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 1.39162102 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.39069205 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.36311638 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.29512017 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.28688908 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25600820 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.22671707 |
| 45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.22563009 |
| 46 | Axon guidance_Homo sapiens_hsa04360 | 1.18433405 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.14410119 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.12595329 |
| 49 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.07134733 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.05997987 |
| 51 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.05912871 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.05585156 |
| 53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.04592045 |
| 54 | RNA degradation_Homo sapiens_hsa03018 | 1.04404705 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 1.01768790 |
| 56 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.00883741 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.99437556 |
| 58 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.97553034 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.97498475 |
| 60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96757683 |
| 61 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94999811 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.94045874 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.91062411 |
| 64 | Melanogenesis_Homo sapiens_hsa04916 | 0.90964655 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89507712 |
| 66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.87248814 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87009646 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85614367 |
| 69 | RNA polymerase_Homo sapiens_hsa03020 | 0.85554238 |
| 70 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.84042248 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.83844400 |
| 72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.83540017 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82368547 |
| 74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81932062 |
| 75 | Glioma_Homo sapiens_hsa05214 | 0.80867288 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.79660399 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.79344198 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78371836 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77684539 |
| 80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.77510620 |
| 81 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.76944479 |
| 82 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.76516331 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.76222633 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73797933 |
| 85 | Tight junction_Homo sapiens_hsa04530 | 0.71985593 |
| 86 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.70719359 |
| 87 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69260349 |
| 88 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.68834060 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67962931 |
| 90 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.67876496 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67381152 |
| 92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.67196062 |
| 93 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.64556994 |
| 94 | Base excision repair_Homo sapiens_hsa03410 | 0.64035193 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.60579975 |
| 96 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.60418509 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60380576 |
| 98 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60362191 |
| 99 | Protein export_Homo sapiens_hsa03060 | 0.60244680 |
| 100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60153927 |
| 101 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.59323194 |
| 102 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59163041 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58786248 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58243169 |
| 105 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57589550 |
| 106 | Homologous recombination_Homo sapiens_hsa03440 | 0.55302828 |
| 107 | Phototransduction_Homo sapiens_hsa04744 | 0.54571349 |
| 108 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54537704 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54400353 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54369852 |
| 111 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49266188 |
| 112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47954655 |
| 113 | Bile secretion_Homo sapiens_hsa04976 | 0.47577373 |
| 114 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43886640 |
| 115 | Phagosome_Homo sapiens_hsa04145 | 0.43496106 |
| 116 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42941219 |
| 117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42468408 |
| 118 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42211147 |
| 119 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42040035 |
| 120 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.41936703 |
| 121 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40965241 |
| 122 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.39886976 |
| 123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39420247 |
| 124 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.38708055 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.38587830 |
| 126 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.37252419 |
| 127 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36624923 |
| 128 | Mineral absorption_Homo sapiens_hsa04978 | 0.34512115 |
| 129 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34416320 |
| 130 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33304385 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31902387 |
| 132 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31298991 |
| 133 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.27850378 |
| 134 | Alcoholism_Homo sapiens_hsa05034 | 0.26537263 |
| 135 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.24831994 |
| 136 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23590663 |
| 137 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22019015 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21673055 |
| 139 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.21586161 |
| 140 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.20528620 |
| 141 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.19259452 |
| 142 | Huntingtons disease_Homo sapiens_hsa05016 | 0.18737570 |
| 143 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.17500513 |
| 144 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.16493013 |
| 145 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.16005946 |
| 146 | Parkinsons disease_Homo sapiens_hsa05012 | 0.15053984 |
| 147 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.14975408 |

